|
SCIENCE NEWS
Reprogramming Human Cells without Inserting Genes
A research team has discovered a novel way to turn on stem cell genes in human fibroblasts (skin cells) without the risks associated with inserting extra genes or using viruses. [Worcester Polytechnic Institute, Worcester]
Scientists Program Blood Stem Cells To Become Vision Cells
University of Florida researchers were able to program bone marrow stem cells to repair damaged retinas in mice, suggesting a potential treatment for one of the most common causes of vision loss in older people. [University of Florida, Gainesville]
Stem Cell Hierarchy Offers Potential for Isolating, Growing Cells
The research from their paper finally provides the experimental proof of the existence of a human MSC at the single cell level, a key step that has previously eluded the scientific community. [University of Toronto Institute of Biomaterials and Biomedical Engineering, Toronto]
Scientists Find Way to Coax Human Stem Cells into Becoming T Cells
Canadian researchers have developed a way to direct unspecified human stem cells into becoming progenitor T cells, which then go to the thymus and give rise to mature T cells, an essential ingredient in immune system reconstitution. [Sunnybrook Health Sciences Centre, Toronto]
Study on Sperm Made From Stem Cells Retracted for Plagiarism
A scientific journal has retracted a paper that reported researchers had created human sperm from stem cells because a section of the article was plagiarized, the editor of the journal, Stem Cells and Development, said recently.
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
|
|
INDUSTRY NEWS
Connexon Creative Launches Cord Blood News
Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.
DARA BioSciences, Inc. and America Stem Cell, Inc. Collaborate On Stem Cell Research
DARA BioSciences, Inc. announced recently that the Company is collaborating with America Stem Cell to expand on observations from recent preclinical studies showing that dipeptidylpeptidase inhibitors improve the efficiency of hematopoietic stem cell transplants. [DARA BioSciences, Raleigh]
North Carolina Mayors to Talk Biotech
North Carolina Mayors agreed to pursue priorities in several areas, including support for funding of innovation, educating citizens about biotech job opportunities and benchmarking best practices from communities around the state, according to an announcement that followed the closed-door session.
Living Cell Technologies Raises A$4.2m from a Placement of Shares to Fund Clinical Trials of DIABECELL(R)
Living Cell Technologies Limited announced that it has closed a private placement of share capital raising A$4.2m. [Living Cell Technology, Sydney]
Pluristem's Award from the Israeli Office of the Chief Scientist Increased to $2.3 Million
Pluristem Therapeutics Inc. will receive a total of $2.3 million in funding for its stem cell programs from the Ministry of Industry, Trade and Labor of Israel; an increase from the previously announced amount of $1.9 million. [Pluristem, Haifa]
Pennsylvania Researchers Win Fight over Stem Cell Patent
Two University of Pittsburgh researchers won a patent ruling over their discovery that stem cells gleaned from liposuctioned fat could be used to produce bone, cartilage and muscle. [University of Pittsburgh, Pittsburgh]
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|
